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Abstract
Objectives
Pneumonia is the most common bacterial infection in children at the emergency department
(ED). Clinical prediction models for childhood pneumonia have been developed (using
chest x-ray as their reference standard), but without implementation in clinical practice.
Given current insights in the diagnostic limitations of chest x-ray, this study aims to validate
these prediction models for a clinical diagnosis of pneumonia, and to explore their potential
to guide decisions on antibiotic treatment at the ED.
Methods
We systematically identified clinical prediction models for childhood pneumonia and
assessed their quality. We evaluated the validity of these models in two populations, using a
clinical reference standard (1. definite/probable bacterial, 2. bacterial syndrome, 3. unknown
bacterial/viral, 4. viral syndrome, 5. definite/probable viral), measuring performance by the
ordinal c-statistic (ORC). Validation populations included prospectively collected data of
children aged 1 month to 5 years attending the ED of Rotterdam (2012–2013) or Coventry
(2005–2006) with fever and cough or dyspnoea.
Results
We identified eight prediction models and could evaluate the validity of seven, with original
good performance. In the Dutch population 22/248 (9%) had a bacterial infection, in Coven-
try 53/301 (17%), antibiotic prescription was 21% and 35% respectively. Three models pre-
dicted a higher risk in children with bacterial infections than in those with viral disease (ORC
�0.55) and could identify children at low risk of bacterial infection.
PLOS ONE | https://doi.org/10.1371/journal.pone.0217570 June 13, 2019 1 / 15
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: van de Maat J, Nieboer D, Thompson M,
Lakhanpaul M, Moll H, Oostenbrink R (2019) Can
clinical prediction models assess antibiotic need in
childhood pneumonia? A validation study in
paediatric emergency care. PLoS ONE 14(6):
e0217570. https://doi.org/10.1371/journal.
pone.0217570
Editor: Jose´ Moreira, Fundacao Oswaldo Cruz,
BRAZIL
Received: January 11, 2019
Accepted: May 14, 2019
Published: June 13, 2019
Copyright: © 2019 van de Maat et al. This is an
open access article distributed under the terms of
the Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: Individual participant
data that underlie the results reported in this article
will be made available at request after de-
identification, beginning 12 months and ending 10
years following article publication. Data will be
shared with investigators who provide a
methodologically sound proposal, designed to
achieve aims in the approved proposal, or for
individual participant data meta-analysis. Proposals
should be directed to r.oostenbrink@erasmusmc.nl
/ secretariaatalkg@erasmusmc.nl; to gain access,
Conclusions
Three clinical prediction models for childhood pneumonia could discriminate fairly well
between a clinical reference standard of bacterial versus viral infection. However, they all
require the measurement of biomarkers, raising questions on the exact target population
when implementing these models in clinical practice. Moreover, choosing optimal thresholds
to guide antibiotic prescription is challenging and requires careful consideration of potential
harms and benefits.
Introduction
Community-acquired pneumonia is the second largest cause of childhood mortality world-
wide [1]. Despite improvements over the past decades, lower respiratory tract infections are
still responsible for 103.3 deaths per 100,000 people in children under five years globally, with
large differences across regions [2]. Respiratory tract infections are also a common reason for
emergency department (ED) visit and the most frequent indication for antibiotic prescription
in children [1, 3]. Discriminating bacterial infections that require antibiotic treatment from
viral, self-limiting disease is one of the biggest diagnostic challenges in childhood pneumonia.
Chest x-ray is no longer recommended as the gold standard for bacterial pneumonia [4], and
routinely available biomarkers are not pathognomonic for this diagnosis [5]. At the same time,
accurate diagnosis of bacterial infection is crucial, since misuse of antibiotics is associated with
increased antimicrobial resistance, which in turn also causes morbidity and mortality [6]. Cur-
rent antibiotic prescription for suspected pneumonia in Western countries ranges from 23–
59% with wide acknowledgement that a considerable proportion of these antibiotics are not
necessary [3, 7].
In order to standardize the evaluation and treatment of children suspected of pneumonia,
clinical decision support systems could be useful tools to classify children into a high or low
risk profile [8]. Multiple clinical prediction models for childhood pneumonia have been devel-
oped. Even though their current use in clinical practice is limited, they may play a role as treat-
ment decision support, thereby improving rational antibiotic prescription. However, since
those models are mainly developed with chest x-ray as their reference standard, it is unclear if
they can also validly predict a clinically based diagnosis of pneumonia. Moreover, the question
is whether these models can be translated into clinical practice by guiding decisions on antibi-
otic treatment.
This study aims to systematically search available clinical prediction models for childhood
pneumonia in ED settings in high-income countries, to evaluate their validity using a new,
clinical diagnosis reference standard, and to explore their potential to guide decisions on anti-
biotic treatment.
Methods
Selection and quality assessment of prediction models
A systematic search for prediction models of childhood pneumonia was performed in Embase,
Medline Ovid, Web of science, PubMed and Google scholar in September 2017. We included
studies on diagnosis and treatment of uncomplicated childhood pneumonia in ED settings in
Western countries published since 2000 (see search strategy and exclusion criteria, S1 Text).
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JvdM and BK performed the selection independently, discrepancies were discussed within the
research group and decided using consensus.
We evaluated the clinical prediction models for their quality and diagnostic value. Quality
assessment was performed by JvdM and checked by RO, using the QUADAS-2 tool for diag-
nostic studies [9]. We assessed their level of validation using the guideline proposed by the Evi-
dence-Based Working Group [10] with one added category as described by Reilly [11],
ranging from level 1 ‘derivation of the model without validation’ to level 5 ‘proven by broad
impact analysis’.
Validation study
Validation populations. We retrospectively evaluated the validity of the identified predic-
tion models in two study populations [12, 13]. Population 1 included 248 children aged 1
month to 5 years presenting at the ED in 2012–2013 with fever and cough or dyspnoea, from a
prospective study at the Erasmus MC—Sophia, Rotterdam, the Netherlands [12]. Population 2
included 301 children aged 3 months to 5 years presenting with fever and respiratory symp-
toms at a paediatric assessment unit at the University Hospitals Coventry and Warwickshire
NHS Trust, United Kingdom (UK), in 2005–2006 [13]. In both databases children with
comorbidity related to increased risk of bacterial infection or complications were excluded,
such as severe neurological impairment, immunodeficiency and severe pulmonary or cardiac
defects. Follow-up was available for both populations, reducing the risk of missing (untreated)
serious infections. The studies in these populations were approved by the Medical Ethics Com-
mittee of the Erasmus MC (Rotterdam) and the Coventry Local Research Ethics Committee.
Written informed consent was obtained for both populations [12, 13].
Reference standard. As chest x-ray is no longer recommended as a gold standard in clini-
cal practice, the diagnosis of bacterial pneumonia is mostly a clinically based diagnosis. A
model that may reflect this clinical approach, is an algorithm published by Herberg et.al., clas-
sifying the potential aetiology of febrile illness in children [14]. For this study, we used a refer-
ence standard adapted to this model, classifying patients’ cause of respiratory tract infection
from bacterial to viral (see S1 Fig). First, we pre-specified what working diagnosis would be
classified as ‘bacterial syndrome’, ‘viral syndrome’ or ‘unknown bacterial/viral’, the first step of
the algorithm. Then we categorized all patients based on their working diagnosis as docu-
mented in the different databases. We used the working diagnosis that was attributed by the
attending clinician at the end of the ED visit, based on patient assessment and routine diagnos-
tic tests. As a second step, we used identification of bacteria or viruses and CRP-level (>60
mg/l or�60mg/l) to further differentiate the clinical diagnosis. Diagnostic tests from routine
care included viral PCR of nasopharyngeal swab and blood cultures, as performed at the dis-
cretion of the clinician. Given a low number of pathogens identified we had few definite diag-
noses, so we classified patients into to five categories: definite or probable bacterial (1),
bacterial syndrome (2), unknown bacterial or viral (3), viral syndrome (4) and definite or
probable viral (5). For example, a child presenting with bronchiolitis (viral syndrome at first
step), no virus or bacteria identified and a CRP-level of>60mg/l would be classified as having
a viral syndrome. A child with a working diagnosis of pneumonia (unknown viral/bacterial at
first step), the CRP-level would lead to either bacterial syndrome (in case of high CRP), viral
syndrome (in case of low CRP) or remain unknown bacterial/viral (in case of no CRP per-
formed). Patients with a bacterial and viral co-infection were classified as bacterial infection,
given the consequences for treatment.
Statistical analysis. Missing values were imputed 10 times using the mice package in R
(version 3.3.2), resulting in 10 separate datasets with complete (imputed) information. The
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imputation model included information about clinical signs and symptoms, referral, diagnos-
tic tests and treatment. We performed all analyses of the validation on the 10 imputed datasets
and then averaged the results [15]. When a variable of a prediction model was completely
missing in our database, multiple imputation was not possible and we used a proxy (e.g.
‘retractions’ as a proxy variable for ‘dyspnoea’, if ‘dyspnoea’ was not available). For continuous
variables, the prevalence of that variable in the original derivation population of the prediction
model was used (mean imputation) [16]. CRP-level was truncated at the level of 225 mg/L, fol-
lowing the study of Nijman [17].
We evaluated the validity of those prediction models of which more than 50% of the predic-
tors were available in our database, assuming this as a minimum for credible predictions [16].
We calculated the risk of bacterial pneumonia using each of the included prediction models
for all children in our study populations, illustrated by histograms and boxplots. To measure
performance, we calculated the ordinal c-statistic (ORC)–a measure similar to the area under
the receiver-operating-curve (AUC), but for ordinal instead of dichotomous outcomes. This
statistic can be interpreted as the probability that two cases of randomly selected outcome cate-
gories are correctly ranked [18]. We defined models with an ORC of at least 0.55 as performing
well and explored their potential to guide antibiotic prescription. For this purpose, we evalu-
ated the harms and benefits of withholding antibiotics in low-risk patients, compared to the
observed usual care in which treatment decisions were based on clinical judgment and routine
diagnostic tests. Benefit was defined as the potential reduction of antibiotic prescription and
harm as the potential risk of under treatment. Under treatment was defined as children that
were classified as having a bacterial infection and who had been treated with antibiotics, but
whom the prediction model classified as low-risk. We explored different thresholds for the
prediction models to define low-risk and evaluated their effect on harms and benefits. All anal-
yses were performed using SPSS (IBM version 24.0) and R (version 3.3.2).
Results
Identification, quality and original performance of prediction models
We identified 4324 unique articles (after removal of duplicates). Based on title and abstract
4176 articles were excluded as not relevant (see S2 Fig). After full-text selection and searching
references, 11 articles were eligible for inclusion (see Table 1). Eight were primary derivation
studies, describing different prediction models [17, 19–25], three were validation or impact
studies of three of these models [12, 26, 27] and one derivation study also included the valida-
tion of another model [25]. Even though VandenBruel’s model was derived mainly in general
practice setting, it was also validated in an ED setting, and therefore included in our study.
Most studies included children up to the age of 16, but the majority of the included patients in
all studies were under five. Most studies had radiographic pneumonia as their reference stan-
dard, except for VandenBruel’s study that used hospitalization for radiographic pneumonia as
its reference standard (Table 1). All prediction models aimed to improve clinical decision-
making in the child suspected of bacterial pneumonia. Three studies mainly focused on deci-
sions on diagnostic tests [19, 21, 23]; the other studies also mentioned the potential of the
models to improve management decisions on antibiotic treatment, admission or referral [17,
20, 22, 24, 25].
In general the quality of the prediction models was moderate (see Table 1 and S3 Fig) with
3 models having some risk of bias [19, 21, 24] and one study with concerns about the applica-
bility [20]. Nijman’s model was evaluated most thoroughly including impact analysis [17]. The
models by VandenBruel, Lynch and Oostenbrink were broadly validated in previous studies
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Table 1. Characteristics of clinical prediction models.
Clinical
prediction
rule
Setting Population Original
reference
standard
Prevalence
pneumonia
Statistical
model
Predictor
variables
Performance Level of
evidence��
QUADAS-2
Risk classification (high versus low
risk)
Sensitivity Specificity LR+ LR- risk of bias /
concern
applicability
1. Mahabee
(2005)[23]
US 2m - 5y,
cough + 1 of
following:
labored/
rapid/noisy
breathing;
chest/
abdominal
pain; fever
radiographic
pneumonia
44/510 (8.6) MLRM age�12 months,
respiratory rate
�50/min,
oxygen
saturation
�96%, nasal
flaring in age
<12months
63.6 77 2.8 0.5 1 low / low
2. Bruel, van
den (2007)
[20]
BE� < 17y, acute
illness
hospital
admission for
radiographic
pneumonia
15/3981
(0.4)
CART dyspnea,
’something is
wrong’
93.8 93.2 13.9 0.07 3 low / high
Verbakel
(validation 1,
2013)[26]
NL " " 17/506 (3.3) 94.1 44.6 1.7 0.13 NA,
different
datasets
Verbakel
(validation 2,
2013)
UK " " 131/2687
(4.9)
92.4 41.4 1.58 0.18
Verbakel
(validation 3,
2013)
NL " " 114/1750
(6.5)
65.8 43.1 1.16 0.79
Verbakel
(validation 4,
2013)
NL " " 54/595 (9.1) 81.5 45.5 1.49 0.41
Verbakel
(validation 5,
2013)
UK " " 67/700 (9.6) 26.9 89.1 2.46 0.82
3. Neuman
(2011)[21]
US < 21, chest
X-ray for
suspected
pneumonia
radiographic
pneumonia
422/2574
(16.4)
CART oxygen
saturation
�92%, history of
fever, wheezing,
focal rales, chest
pain, focal
decreased breath
sounds
90.1 21.6 1.2 0.4 1 some / low
Probability (predicted
risk in %)
AUC
4. Lynch
(2004)[19]
US 1-16y, chest
X-ray for
suspected
pneumonia
radiographic
pneumonia
204/570
(35.8)
MLRM fever, decreased
breath sounds,
crackles,
tachypnea
0.67 3 some / low
Bilkis
(validation,
2010)[27]
US " 179/257
(69.6)
0.7 some / some
(Continued)
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Table 1. (Continued)
Clinical
prediction
rule
Setting Population Original
reference
standard
Prevalence
pneumonia
Statistical
model
Predictor
variables
Performance Level of
evidence��
QUADAS-2
Risk classification (high versus low
risk)
Sensitivity Specificity LR+ LR- risk of bias /
concern
applicability
5.
Oostenbrink
(2013)[24]
NL 1m - 16y,
fever and
cough
nodular
infiltration or
consolidation
on radiograph
/ rule out
pneumonia by
noneventful
followup /
consensus
78/504
(15.5)
MLRM ill appearance,
tachypnea, O2
<94%, CRP
0.79 3 some / low
Oostenbrink
(validation 1,
2013)
NL " 58/420
(13.8)
0.81
Oostenbrink
(validation 2,
2013)
NL " 27/366 (7.4) 0.86
6. Craig
(2010)[22]
AU <5y, fever consolidation
on radiograph
533/15781
(3.4)
MLRM general
appearance,
cough,
temperature,
breathing
difficulty,
abnormal chest
sounds, chronic
disease, capillary
refill time,
urinary
symptoms,
elevated
respiratory rate,
crackles,
pneumococcal
vaccine status,
elevated heart
rate, felt hot,
meningococcal
vaccine state,
infectious
contacts, crying,
fluid intake,
respiratory
symptoms,
diarrhoea,
bulging
fontanelle, male
sex, focal
bacterial
infection,
abnormal ear/
nose/throat
signs, age, rash,
stridor, wheeze
0.84 2 low / low
Craig
(validation,
2010)
AU " 193/5584
(3.5)
0.84 low / low
(Continued)
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[19, 20, 24]; those by Mahabee-Gittens, Neuman, Craig and Irwin were only derived or vali-
dated in one setting by the original authors [21–23, 25].
Three prediction models provided a risk classification (high versus low risk), based on the
presence of specific symptoms [20, 21, 23]. Of these models, sensitivity at model development
was moderate to good, with varying specificity (see Table 1). Only VandenBruel’s model was
validated in different settings, performing poorly due to high sensitivity and low specificity in
three settings, the opposite in another setting, and in a last setting both poor sensitivity and
specificity [26]. The other four prediction models provided a probability (predicted risk in %)
of pneumonia, based on a multiple logistic regression model [17, 19, 24, 25]. These models
showed moderate to good performance at development (AUC ranging from 0.67 to 0.84) as
well as in the validation studies [22, 24, 26].
Validation study
Table 2 shows the baseline characteristics of the two populations. Using the clinical diagnosis,
bacterial infection rate ranged from 9–17% and 38–41% were classified as ‘unknown’. Of this
latter category 74–87% recovered without antibiotics. We included seven prediction models in
our validation study. We did not assess validity of Craig’s model as only 14/28 variables were
Table 1. (Continued)
Clinical
prediction
rule
Setting Population Original
reference
standard
Prevalence
pneumonia
Statistical
model
Predictor
variables
Performance Level of
evidence��
QUADAS-2
Risk classification (high versus low
risk)
Sensitivity Specificity LR+ LR- risk of bias /
concern
applicability
7. Nijman
(2013)[17]
NL 1m - 15y,
fever
nodular
infiltration or
consolidation
on radiograph;
rule out
pneumonia by
noneventful
followup
171/2717
(6.3)
MLRM age, sex,
duration of
fever,
temperature,
respiratory rate,
heart rate,
oxygen
saturation,
capillary refill,
retractions, ill
appearance, CRP
0.81 4 low / low
Nijman
(validation,
2013)
NL " 59/487
(12.1)
0.81 low / low
De Vos
(validation,
2015) [12]
NL " 33/439 (7.5) 0.83 low / low
8. Irwin
(2017)[25]
US <16y,
(history of)
fever
respiratory
symptoms,
signs and focal
consolidation
on radiograph
63/532 (12) MLRM CRP, respiratory
rate, normal air
entry, resistine,
procalcitonin
0.84 1 low / low
m = months, y = years, ED = emergency department, GP = general practice, US = United States of America, BE = Belgium, NL = the Netherlands, AU = Australia,
UK = United Kingdom
CART = classification and regression tree, MLRM = multivariable linear regression model, LR+ = positive likelihood ratio, LR- = negative likelihood ratio, AUC = area
under the receiver operating curve
aderived in general practice and emergency department, validated in ED
bas described by Reilly (range 1 (only derived) to 5 (proven by broad impact analysis)[11]
https://doi.org/10.1371/journal.pone.0217570.t001
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present in both databases. Lynch–having only 2/4 variables available–was not validated in the
Coventry database. The supplementary S1 Table gives an overview of all variables and proxies
of the validated prediction models. Mahabee-Gittens published a regression model providing a
probability, but the coefficients to calculate this probability were not available from the author
[23]. We therefore used the presence of one or more of the included variables classifying
patients at high risk of bacterial pneumonia. VandenBruel published a general prediction
model for febrile children, and one for pneumonia; for this review we only used the pneumo-
nia model [20]. Neuman used a decision tree to classify patients into 3 categories (high/inter-
mediate/low risk of pneumonia) [21]. In this model ‘history of fever’ discriminated
intermediate from low risk, but since fever was an inclusion criteria of all our validation popu-
lations, only high and low risk patients were identified, based on the first step of the decision
tree (oxygen saturation <92%).
Performance of prediction models. The performance of the three models with a risk clas-
sification (high/low risk) is shown in Fig 1A. The white bars indicate the number of children
with predicted low risk of pneumonia and the grey bars the number of patients with predicted
high risk, across the five reference standard categories (bacterial to viral infection). For exam-
ple, when we used Mahabee-Gittens’ model to predict the risk of having a bacterial pneumonia
Table 2. Baseline characteristics of validation populations.
Rotterdam, n = 248 Coventry, n = 301
Predictor variables median (IQR) or n(%) median (IQR) or n(%)
Age (months) 14 (7–27) 19 (12–31)
Gender (male) 148/248 (60%) 174/301 (58%)
Temperature (C˚) 38.2 (37.4–39.1) 38.2 (37.5–39.1)
Duration of fever (days) 3 (2–4) not available
Tachypnea 81/183 (44%) 154/258 (60%)
Tachycardia 66/207 (32%) 191/294 (65%)
Oxygen saturation (%) 98 (97–100) 97 (95–98)
Ill appearance 35/149 (23%) 1/301 (0%)
Dyspnoea 106/248 (43%) 81/301 (27%)
Decreased breath sounds 12/136 (9%) not available
Crackles 30/127 (24%) not available
Focal rales 67/151 (44%) not available
Retractions 68/107 (64%) not available
Nasal flaring 29/58 (50%) not available
Prolonged capillary refill (>2sec) 10/53 (19%) 58/187 (31%)
Diagnostics and treatment
CRP measured 94/248 (38%) 109/301 (36%)
CRP (mg/L) 16 (7–42) 45 (19–122)
X-ray performed 42/248 (17%) 67/301 (22%)
Antibiotics prescribed 51/248 (21%) 105/301 (35%)
Clinical diagnosis (S1 Fig)
Definite or probable bacterial 18/248 (7%) 37/301 (12%)
Bacterial syndrome 4/248 (2%) 16/301 (5%)
Unknown 94/248 (38%) 122/301 (41%)
Viral syndrome 59/248 (24%) 72/301 (24%)
Definite or probable viral 73/248 (29%) 54/301 (18%)
IQR = interquartile range
https://doi.org/10.1371/journal.pone.0217570.t002
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in our two validation populations, we observed that this model predicts most children as hav-
ing a high risk of pneumonia (grey bars), including most children with viral infections. Using
VandenBruel’s model, we observed low as well as high predicted risks across all 5 diagnosis
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Fig 1. Performance of prediction models. a. Models with risk classification (high vs. low predicted risk) b. Models with probability (% predicted risk).
DPB = definite or probable bacterial, BS = bacterial syndrome, U = unknown, VS = viral syndrome, DPV = definite or probable viral; ORC = ordinal c-statistic;
SD = standard deviation.
https://doi.org/10.1371/journal.pone.0217570.g001
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categories. Almost all children were assigned to a low risk group using Neuman’s model,
including children with bacterial infections.
Fig 1B shows the performance of the prediction models providing a probability. Again, pre-
dictions are shown across the five diagnosis categories for each model and for both popula-
tions, illustrated by a boxplot. Lynch’s model predicted high risk of pneumonia (around 90%)
for all children, with little variation across the different outcome categories (see S4 Fig), and
did not contribute to discrimination between bacterial or viral disease. The models by Oosten-
brink, Nijman and Irwin assigned higher risks to children with bacterial infections than to the
children with viral infections, confirmed by a moderate ordinal c-statistic of�0.55 (see Fig
1B).
To assess the clinical relevance of these findings, we explored the potential of the last three
models to define low-risk patients possibly not needing antibiotic treatment. For example,
applying a risk threshold of 10% using Nijman’s model would classify 130 children (52%) in
the Rotterdam population as being at low risk of bacterial pneumonia (see Table 3, details in
Table 3. Clinical consequences of using prediction models to guide antibiotic prescription.
Rotterdam, n = 248 Coventry, n = 301
Observed antibiotic prescription, n (%) 51 (21%) 105 (35%)
Predictions by Nijman’s model
Threshold 10% Rotterdam Coventry
Number of children below threshold (low-risk group) 130 (52%) 193 (64%)
Expected antibiotic prescription when guided by threshold (benefit) 35 (14%) 49 (16%)
Expected under treatment when prescription was guided by threshold
(harm)a
5 (2%) 15 (5%)
Threshold 15%
Number of children below threshold 167 (67%) 229 (76%)
Expected antibiotic prescription when guided by threshold 28 (11%) 36 (12%)
Expected under treatment when prescription was guided by thresholda 8 (3%) 22 (7%)
Predictions by Oostenbrink’s model
Threshold 10% Rotterdam Coventry
Number of children below threshold 69 (28%) 94 (31%)
Expected antibiotic prescription when guided by threshold 44 (18%) 77 (26%)
Expected under treatment when prescription was guided by thresholda 0 (0%) 8 (3%)
Threshold 15%
Number of children below threshold 110 (44%) 178 (59%)
Expected antibiotic prescription when guided by threshold 35 (14%) 51 (17%)
Expected under treatment when prescription was guided by thresholda 2 (1%) 13 (4%)
Predictions by Irwin’s model
Threshold 10% Rotterdam Coventry
Number of children below threshold 100 (40%) 155 (51%)
Expected antibiotic prescription when guided by threshold 38 (15%) 64 (21%)
Expected under treatment when prescription was guided by thresholda 5 (2%) 15 (5%)
Threshold 15%
Number of children below threshold 120 (48%) 198 (66%)
Expected antibiotic prescription when guided by threshold 33 (13%) 48 (16%)
Expected under treatment when prescription was guided by thresholda 8 (3%) 22 (7%)
a Number of children with a bacterial infection who were treated with antibiotics, but who were classified as low-risk
according to the used prediction model and threshold
https://doi.org/10.1371/journal.pone.0217570.t003
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S2 Table). Of these children 16 were currently treated with antibiotics. If this threshold would
be used in clinical practice, and antibiotics would be withheld in all low-risk children, the over-
all antibiotic prescription rate would reduce from 21% (observed antibiotic prescription) to
14% (expected antibiotic prescription) in the Rotterdam population and from 35% to 16% in
the Coventry population (Table 3). The potential risk of under treatment (e.g. withholding
antibiotics in children with a bacterial infection who were currently treated with antibiotics)
would be 2% (Rotterdam) and 5% (Coventry). Similar benefits and harms were observed when
applying the models of Oostenbrink and Irwin. A threshold of 15% would lead to greater
reduction in antibiotic prescription, but at a higher risk of under treatment.
Discussion
We identified eight clinical prediction models for childhood pneumonia by literature review.
Following changing perspectives on a relevant reference standard for childhood pneumonia,
we could assess the validity of seven of them for a clinical diagnosis of bacterial, unknown bac-
terial/viral or viral infection. Three models–with good original performance and quality–
assigned a higher risk to children with bacterial infection than to those with viral infection,
with the potential of proper selection of children who may recover without antibiotics.
An important strength of our study is the broad validation of multiple prediction models in
prospective cohorts including over 500 patients in two different European acute care settings.
Our populations were rather heterogeneous in terms of their clinical characteristics, increasing
the generalizability of our findings. A limitation is the heterogeneity of the information avail-
able, and missing values in general, which is related to the use of already existing datasets. We
have accounted for this by multiple imputation or by using proxies where possible. Another
limitation is the retrospective classification of the clinical diagnosis, based on the working
diagnosis by the treating physician not blinded for clinical features and diagnostic tests.
Because none of these clinical features or tests alone determined classification into a final diag-
nosis category, we believe this potential bias is limited. Diagnostic tests were performed at the
discretion of the treating clinician, and included chest x-rays mainly. For 22 patients a definite
viral or bacterial test was recorded to be positive, however, we had no data on the total per-
formed viral/bacterial tests. Previous studies in these settings have shown that these are per-
formed in about 10% of febrile children [12, 13]. Validity assessment of the model by
Mahabee-Gittens was limited by the absence of the original coefficients. Of Irwin’s model only
3 out of 5 predictor variables were present, for the other two variables we used mean imputa-
tion. This may have underestimated the model’s discriminative value; but given the small effect
sizes of the missing variables, we consider this effect limited [16].
We should appreciate several differences between our study populations and the popula-
tions the models were originally derived on. Since our populations included febrile children at
the ED, it is not surprising that we observed less variability in the predicted probabilities in the
validation of Neuman and Lynch’ models, since fever was one of their predictor variables. Fur-
thermore, differences in pneumonia prevalence in the derivation populations (6–36%) of the
models may explain systematic differences in predicted probabilities in 4 models [17, 19, 24,
25, 28]. In general, correcting for this involves recalibration (calibration-in-the-large) of the
model to a new target population [28]. However, this type of recalibration does not influence
discrimination (the ordinal c-statistic), and thus not our conclusions. It may, however, explain
the variable impact the suggested thresholds have using the different models. Next, the type of
reference standard (radiographic pneumonia vs. clinical diagnosis) differed between deriva-
tion and validation studies, as was the purpose of our study. Given the diagnostic limitations
of chest X-rays, we chose to define our reference standard following Herberg’s classification
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[14]. It must be noted that this choice was not proposed as a new gold standard, but rather
used as a model that may reflect our best current practice. In our aim to translate prediction
models into clinical practice, we observed that the performance varied by type of model. We
observed that the models using the probability scale had better diagnostic performance
(reflected by a higher ORC statistic) than those using a risk classification (high/low risk). This
can partly be explained by the ability to adjust risk thresholds–with a direct link to the harm-
benefit ratio–more easily in models using the probability scale. Models using a risk classifica-
tion have a fixed threshold and lack this flexibility and may therefore show lower diagnostic
performance when validated according to a new reference standard.
In order to improve rational use of antibiotics in children with respiratory infections, there
is a need to improve discrimination between bacterial and viral, self-limiting disease. We
showed that three of seven tested clinical prediction models could identify a low-risk group of
children with self-limiting disease in an ED population fairly well and we believe those three
have the potential to improve treatment decisions. Those models include a combination of
signs of general illness and/or respiratory distress and biomarkers. The availability of biomark-
ers will influence the feasibility of implementation of these models in clinical practice. The
models of Oostenbrink and Nijman include CRP measurement, Irwin’s model includes CRP,
procalcitonin and resistin. Given the wide availability of point-of-care CRP tests the first two
models will be most feasible for routine use in the ED.
Another important challenge to be faced before prediction models can be implemented as
decision tools in clinical practice is to choose optimal decision thresholds, adapted to the appro-
priate target population. A balance is needed between the benefit of reducing unnecessary anti-
biotic prescription and the harm of potential under treatment of bacterial infections. The prior
risk of severe illness in a population is an important consideration. For example, in settings with
high prevalence of comorbidity, the course of pneumonia will generally be more severe and
missing a serious infection will have worse consequences than in a low-risk population. Next,
the natural course of the disease should be taken into account. Last, access to (good quality)
healthcare is important. In a setting with limited possibility for patient follow-up, potential risks
of under treatment will higher. Given the natural course of pneumonia (developing over days
instead of hours), a watchful waiting approach instead of immediate antibiotic treatment in
children with uncomplicated pneumonia with a predicted risk<10–15% might be justified in
settings with good access to care, in the presence of a proper safety-netting strategy for unex-
pected disease course. In low resource settings or high-risk populations lower thresholds may
be reasonable. Before implementing treatment interventions based on these prediction models
in clinical practice, a prospective study is needed to evaluate the overall impact of treating chil-
dren according to such a prediction model, compared to usual care. Such a study should assess
the feasibility and safety of the suggested thresholds for that specific setting.
Three out of seven clinical prediction models for pneumonia could discriminate fairly well
between a new reference standard of bacterial and viral infection in children presenting at the
ED. However, they all require the measurement of biomarkers, raising questions on the exact
target population when implementing these models in clinical practice. Moreover, choosing
optimal decision to guide antibiotic prescription is challenging and requires careful consider-
ation of potential harms and benefits. Future research should focus on the feasibility and safety
of treatment based on chosen decision thresholds for specific settings.
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